ProteomEdge secured 7.8M SEK in funding to accelerate commercialization and appointed a new CEO.
ProteomEdge™ is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins
ProteomEdge™ is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins. Our proprietary analysis platform offers cleavable heavy-isotope labeled protein standards for targets of both clinical and research interests that is versatile and easy to use.